Literature DB >> 16275025

Imidazole derivatives as antioxidants and selective inhibitors of nNOS.

V Sorrenti1, L Salerno, C Di Giacomo, R Acquaviva, M A Siracusa, A Vanella.   

Abstract

The reperfusion of ischemic tissue often delays its physiological and functional recovery; this paradoxical effect is ascribed to increased release of free radicals including O(2)(-) and NO. For these reasons, scavenging reactive oxygen species or inhibition the NO synthesis has been shown to result in an enhanced neuronal survival after cerebral ischemia. Many authors believe that therapy for stroke patients would be a cocktail of drugs with various mechanisms of action. Combination therapy is a difficult and complicated avenue for drug development because of the possibility of drug-drug interactions. An alternative approach would be to combine multiple activities within the same compound. In consideration of the free-radical scavenging and inhibitory effect on NOS of various natural and synthetic compounds, the aim of this study was to analyze the antioxidant properties of some imidazole derivatives previously synthesized in our laboratory. Results obtained in the present study provide evidence that tested compounds exhibit interesting antioxidant properties, expressed either by their capacity to scavenge free radicals or their ability to reduce lipid peroxidation. In particular, compounds A and B represent chemical structures which can be easily modified to improve the observed antioxidant properties and to provide new therapeutic strategies focused on multiple downstream events.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16275025     DOI: 10.1016/j.niox.2005.09.005

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  8 in total

1.  A Novel Tetrasubstituted Imidazole as a Prototype for the Development of Anti-inflammatory Drugs.

Authors:  Marcus Vinicius P S Nascimento; Antonio C M Munhoz; Lais C Theindl; Eduarda Talita B Mohr; Najla Saleh; Eduardo B Parisotto; Thaís A Rossa; Ariane Zamoner; Tania B Creczynski-Pasa; Fabíola B Filippin-Monteiro; Marcus M Sá; Eduardo Monguilhott Dalmarco
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

Review 2.  Significance of brain tissue oxygenation and the arachidonic acid cascade in stroke.

Authors:  Cameron Rink; Savita Khanna
Journal:  Antioxid Redox Signal       Date:  2010-12-04       Impact factor: 8.401

3.  An imidazole modified lipid confers enhanced mRNA-LNP stability and strong immunization properties in mice and non-human primates.

Authors:  Manon Ripoll; Marie-Clotilde Bernard; Céline Vaure; Emilie Bazin; Sylvie Commandeur; Vladimir Perkov; Katia Lemdani; Marie-Claire Nicolaï; Patrick Bonifassi; Antoine Kichler; Benoit Frisch; Jean Haensler
Journal:  Biomaterials       Date:  2022-05-07       Impact factor: 15.304

Review 4.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

Review 5.  Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain.

Authors:  Paramita Mukherjee; Maris A Cinelli; Soosung Kang; Richard B Silverman
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

6.  Characterizing metabolic inhibition using electrochemical enzyme/DNA biosensors.

Authors:  Dominic O Hull; Besnik Bajrami; Ingela Jansson; John B Schenkman; James F Rusling
Journal:  Anal Chem       Date:  2009-01-15       Impact factor: 6.986

7.  Synthesis and Spectroscopic Studies of Phenanthroimidazole-Imine Derivatives and Evaluation of Their Antioxidant Activity.

Authors:  Sibel Gülle; Seçil Çelik Erbaş; Ataç Uzel
Journal:  J Fluoresc       Date:  2017-10-07       Impact factor: 2.217

8.  Synthesis and biological study of acridine-based imidazolium salts.

Authors:  Olla Sharhan; Thorsten Heidelberg; Najiahah Mohd Hashim; Abbas Abdulameer Salman; Hapipah Mohd Ali; Soher Nagi Jayash
Journal:  RSC Adv       Date:  2018-11-20       Impact factor: 4.036

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.